Sunscreen slow down: The US FDA's sluggish approval of new sunscreens frustrates physicians, manufacturers, and consumers

Publisher： Blackwell Publishing

E-ISSN： 1097-0142|121|17|2861-2862

ISSN： 0008-543X

Source： Cancer, Vol.121, Iss.17, 2015-09, pp. : 2861-2862

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Clamp down on Rx drugs without US FDA approval

By  

Reactions Weekly, Vol. 1, Iss. 1106, 2006-01 ,pp. : 3-3

Adis International

Access to resources Recommend Favorite

US physicians eagerly await approval of new HCV drugs

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 616, 2010-01 ,pp. : 11-11

Adis International

Access to resources Recommend Favorite

The US FDA is responsible for the down-turn in new drug approvals

By  

Inpharma, Vol. 1, Iss. 1646, 2008-01 ,pp. : 3-3

Adis International

Access to resources Recommend Favorite

US FDA shows its teeth with Rotarix approval

By  

Reactions Weekly, Vol. 1, Iss. 1200, 2008-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite

The US FDA has granted tentative approval to Teva Pharmaceutical's Abbreviated New Drug Application (ANDA) for lansoprazole.

By  

Inpharma, Vol. 1, Iss. 1623, 2008-01 ,pp. : 19-19

Adis International

Access to resources Recommend Favorite